On November 15, 2021, "Auhua Endoscopy," a portfolio company of a sub-fund invested in by the master fund managed by Yuanhe Chenchun Venture Capital, was successfully listed on the STAR Market, with stock code: 688212.

Founded in 1994, Auhua Endoscopy specializes in the research, development, manufacturing, and sales of electronic endoscopic equipment and endoscope-based diagnostic and surgical consumables. It is one of the earliest companies in China dedicated to the R&D and production of flexible electronic endoscopes.

In 2005, Auhua Endoscopy launched its first-generation electronic endoscopy system, the VME-2000, one of the earliest domestically produced flexible electronic endoscopes in China. By 2021, the company introduced the VME-2800 electronic endoscopy system, paired with China's first domestically developed electronic nasal and pharyngeal endoscope and electronic bronchoscope. In 2013, Auhua unveiled AQ-100, the country’s first independently developed electronic endoscopy system featuring Chromoendoscopy by Imaging (CBI), enabling early clinical diagnosis and screening for lesions such as early-stage cancers. Then, in 2018, the company rolled out the next-generation AQ-200 Full HD Lightpath endoscopy system, which achieved electrical isolation between devices while significantly enhancing both safety and convenience during clinical procedures.

After more than 20 years of dedication and innovation, AuChuan Endoscopy has broken through numerous key technologies in areas such as endoscopic optical imaging, image processing, endoscope design, and electrical control. Its products are now widely used in clinical departments including gastroenterology, pulmonology, otolaryngology, gynecology, and emergency medicine.

In the future, Auhua Endoscopy will continue to strengthen its advantages in R&D technology, product quality, distribution channels and services, talent development, and local brand positioning—areas where it already excels—while enhancing its core competitive edge and accelerating the import substitution of endoscopic products.